Damian Kettlewell
Director Ejecutivo en Bliss Co. Holdings Ltd. .
Cargos activos de Damian Kettlewell
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Bliss Co. Holdings Ltd.
Bliss Co. Holdings Ltd. Agricultural Commodities/MillingProcess Industries Bliss Co. Holdings Ltd. processes and distributes recreational cannabis. The company was founded by Damian Kettlewell in 2014 and is headquartered in Vancouver, Canada. | Director Ejecutivo | 01/01/2014 | - |
Fundador | 01/01/2014 | - | |
Clairvoyant Therapeutics, Inc.
Clairvoyant Therapeutics, Inc. BiotechnologyHealth Technology Part of Origin Therapeutics Holdings, Inc., Clairvoyant Therapeutics, Inc. is a Canadian biotechnology company focused on mental health through psilocybin therapy. The company is based in Vancouver, Canada. Clairvoyant is changing the face of psychedelic therapy with a speed-to-market clinical strategy designed to enable psilocybin therapy in the US, the EU, and to treat patients living with alcohol use disorder (AUD) beginning in 2026. Clairvoyant's exceptional team, with a proven clinical track record and deep drug development experience, has made it the most advanced company developing psilocybin therapy for the treatment of AUD. Clairvoyant was founded by Damian Kettlewell, Thomas Digby, and has been led by Damian Kettlewell as CEO since incorporation. Clairvoyant Therapeutics was acquired by Origin Therapeutics Holdings, Inc. on July 07, 2022. | Director/Miembro de la Junta | - | - |
Director Ejecutivo | - | - | |
Fundador | - | - |
Historial de carrera de Damian Kettlewell
Antiguos cargos conocidos de Damian Kettlewell.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
BLISSCO CANNABIS CORP | Director/Miembro de la Junta | 01/01/2013 | - |
Director Ejecutivo | 22/02/2018 | - | |
Fundador | 01/01/2013 | - | |
Presidente | 01/01/2013 | - | |
Alliance of Beverage Licensees
Alliance of Beverage Licensees Miscellaneous Commercial ServicesCommercial Services Alliance of Beverage Licensees operates as an advocacy organization representing British Columbia’s private liquor industry. The firm's member includes private liquor stores, pubs, bars, nightclubs, hotel liquor licensees, and various agents, industry suppliers, and benefit providers. The company was founded in 1975 and is headquartered in Vancouver, Canada. | Director/Miembro de la Junta | - | - |
Estadísticas
Internacional
Canadá | 5 |
Operativa
Chief Executive Officer | 3 |
Founder | 3 |
Director/Board Member | 3 |
Sectorial
Process Industries | 3 |
Commercial Services | 2 |
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 4 |
---|---|
Alliance of Beverage Licensees
Alliance of Beverage Licensees Miscellaneous Commercial ServicesCommercial Services Alliance of Beverage Licensees operates as an advocacy organization representing British Columbia’s private liquor industry. The firm's member includes private liquor stores, pubs, bars, nightclubs, hotel liquor licensees, and various agents, industry suppliers, and benefit providers. The company was founded in 1975 and is headquartered in Vancouver, Canada. | Commercial Services |
Bliss Co. Holdings Ltd.
Bliss Co. Holdings Ltd. Agricultural Commodities/MillingProcess Industries Bliss Co. Holdings Ltd. processes and distributes recreational cannabis. The company was founded by Damian Kettlewell in 2014 and is headquartered in Vancouver, Canada. | Process Industries |
BlissCo Cannabis Corp.
BlissCo Cannabis Corp. Agricultural Commodities/MillingProcess Industries BlissCo Cannabis Corp. engages in cultivating, packaging, processing, and distribution of recreational cannabis. Its products include cannabis oil, CBD Shark Shock, AC/DC, Critical Plus, Cheese Quake, White Widow. The company was founded by Damian Kettlewell in 2013 and is headquartered in Langley, Canada. | Process Industries |
Clairvoyant Therapeutics, Inc.
Clairvoyant Therapeutics, Inc. BiotechnologyHealth Technology Part of Origin Therapeutics Holdings, Inc., Clairvoyant Therapeutics, Inc. is a Canadian biotechnology company focused on mental health through psilocybin therapy. The company is based in Vancouver, Canada. Clairvoyant is changing the face of psychedelic therapy with a speed-to-market clinical strategy designed to enable psilocybin therapy in the US, the EU, and to treat patients living with alcohol use disorder (AUD) beginning in 2026. Clairvoyant's exceptional team, with a proven clinical track record and deep drug development experience, has made it the most advanced company developing psilocybin therapy for the treatment of AUD. Clairvoyant was founded by Damian Kettlewell, Thomas Digby, and has been led by Damian Kettlewell as CEO since incorporation. Clairvoyant Therapeutics was acquired by Origin Therapeutics Holdings, Inc. on July 07, 2022. | Health Technology |
- Bolsa de valores
- Insiders
- Damian Kettlewell
- Experiencia